Unveiling Convergence in Healthcare Expenditures in OECD Countries: Evidence From Club Convergence Analysis
Bulletin of Economic Research · 2026-04 · 78 (2) · 268-277
DOI: 10.1111/boer.70021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of Economic Research, online erschienen am 09.11.2025. Verfasst von Şekip Yazgan und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 52 Literaturangaben.
Abstract (Originalsprache)
The purpose of this study is to investigate the convergence dynamics of per capita healthcare expenditures in OECD countries. The study employs the Club Convergence Hypothesis framework, following the approach proposed by Phillips and Sul. There is no overall convergence in per capita health expenditure among OECD countries during the period studied. However, 38 OECD countries were categorized into three final convergence clubs based on per capita health expenditure: Club A includes 23 countries, Club B consists of 9 countries, and Club C comprises 6 countries. A comprehensive analysis of the commonalities and divergences in the healthcare systems of countries within these clubs yields valuable policy recommendations.
Zitieren
APA
Yazgan, Ş., Dikmen, F. H., Ceylan, R., & Başar, D. (2026). Unveiling Convergence in Healthcare Expenditures in OECD Countries: Evidence From Club Convergence Analysis. Bulletin of Economic Research, 78(2), 268-277. https://doi.org/10.1111/boer.70021
Vancouver
Yazgan Ş, Dikmen FH, Ceylan R, Başar D. Unveiling Convergence in Healthcare Expenditures in OECD Countries: Evidence From Club Convergence Analysis. Bulletin of Economic Research. 2026;78(2):268-277. doi:10.1111/boer.70021
BibTeX
@article{Yazgan2026,
author = {Yazgan, Şekip and Dikmen, Fatih Hakan and Ceylan, Reşat and Başar, Dilek},
title = {Unveiling Convergence in Healthcare Expenditures in OECD Countries: Evidence From Club Convergence Analysis},
journal = {Bulletin of Economic Research},
year = {2026},
volume = {78},
number = {2},
pages = {268--277},
doi = {10.1111/boer.70021}
}
EUVIMED